This tiny biotech’s collaboration with Moderna

Today’s big movers inside

June 28, 2024

Good day, 360!

Here are our top investing ideas today. Just a reminder our flagship 0DTE live trading session is moved to today at 11AM EST. Grab yourself a seat HERE for a steal… Be the best prepared trader on the Street!

FOCUS LIST🔎

COSM - Up over 70% in pre after announcing it has signed an exclusive distribution agreement with Pharmalink for its Sky Premium Life Nutraceuticals in the UAE and 130,000 unit purchase order  

CARM - Up over 30% in pre announcing nomination of first in vivo CAR-M development candidate for Hepatocellular Carcinoma under collaboration with Moderna 

DJT - Up over 9% in pre after consensus says Trump crushed Biden in debate  

Kicking Yourself? You should be. 

Life of Service Small Account Journey + Life of Service Jason Bond Picks = ROADMAP

Must contact Davis today to see what he can do:

1-800-585-4488 / [email protected]

Give Jason Bond a chance to show you why he’s earned 4.8/5⭐over 1100+ reviews!

HOTLIST🔥

COSM - Up over 70% in pre after announcing it has signed an exclusive distribution agreement with Pharmalink for its Sky Premium Life Nutraceuticals in the UAE and 130,000 unit purchase order   

Cosmos Health Inc. (COSM) provides a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, cosmetics, nursery, health care and baby products, and medical devices.

In the after-hours yesterday, the company announced it has signed an exclusive distribution agreement with Pharmalink for its Sky Premium Life Nutraceuticals in the UAE and a 130,000 unit purchase order.    

As part of the Agreement, Pharmalink will be responsible for all key functions, including sales and marketing, regulatory affairs, logistics, supply, and distribution of Sky Premium Life products in the UAE. Cosmos Health has secured its first purchase order from Pharmalink for 130,000 units and anticipates receiving orders of more than 500,000 units in the first year and in excess of 3,000,000 units over the next five years.

Pharmalink is one of the largest healthcare organizations in the UAE.

COSM traded up over 70% in the pre-market after the announcement yesterday.

The $1.20 area has acted as a resistance area in the after-hours and pre-market and will be an important level to watch. 

Above it, targets to the upside are $1.30 and then the pre-market high at $1.49. Beyond that, $1.65, $2 and $2.48 come into play. 

Below $1.20, targets to the downside are $1.10, $1, $0.9120. $0.80 and then a gap fill at $0.6790.

CARM - Up over 30% in pre announcing nomination of first in vivo CAR-M development candidate for Hepatocellular Carcinoma under collaboration with Moderna 

Carisma Therapeutics Inc. (CARM) is a clinical-stage cell therapy company that focuses on discovering and developing immunotherapies to treat cancer and other serious diseases in the United States.

In the after-hours yesterday, the company announced the nomination of the first development candidate under its collaboration with Moderna, Inc. The Development Candidate is an in vivo CAR-M targeting Glypican-3 and is designed to treat solid tumors, including hepatocellular carcinoma, the most prevalent type of liver cancer and the fastest-rising cause of cancer-related death in the U.S. This nomination triggers a $2 million milestone payment to Carisma. 

The stock traded up over 30% in the pre-market in reaction to the news. 

$1.6650 has acted as support so far in the pre-market and will be an important level to watch.

Above it, targets to the upside are $1.80, $2, $2.15, $2.30 and then the after-hours high at $2.50. Beyond that, $2.60, $2.90 and $3.15 come into play. 

Below $1.6650, targets to the downside are $1.50, $1.40 and then a gap fill at $1.28.

DON’T BE A CHUMP!

You too, like Tyson, could be knocking out LOTTOS like he does chumps! 

DJT - Up over 9% in pre after consensus says Trump crushed Biden in debate 

Trump Media & Technology Group Corp. (DJT) develops a social media platform known as Truth Social that offers social networking services in the United States. It is a Donald Trump majority owned Social Media company.

Last night CNN hosted the first presidential debate between Donald Trump and Joe Biden. After a poor performance by Biden, the consensus is that Trump won the debate and it wasn’t even close.

DJT traded up over 9% in the pre-market in reaction to last night’s debate.

The $40 level acted as support in the pre-market and will be an important level to watch.

Above it, targets to the upside are $41, $42.50 and then the pre-market high at $43. Beyond that, $47, $50 and $54 come into play. 

Below $40, targets to the downside are $39, $38, $37 and then a gap fill at $36.73.

MARKET NEWS 📰

P.S. Make sure you text “RAGE” to (888) 404-5747 to get all of our latest HOT STOCK ideas!

Questions or concerns about our products? Email [email protected] © Copyright 2022, RagingBull

DISCLAIMER To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at https://ragingbull.com/disclaimer

FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision.

RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment.

RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of https:// ragingbull. com or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers.

RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull. com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull. com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled.

WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication.

Reply

or to participate.